A
Arnon Nagler
Researcher at Sheba Medical Center
Publications - 1435
Citations - 51740
Arnon Nagler is an academic researcher from Sheba Medical Center. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 98, co-authored 1316 publications receiving 44298 citations. Previous affiliations of Arnon Nagler include French Institute of Health and Medical Research & University of Paris.
Papers
More filters
Journal ArticleDOI
Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation
Nicolaus Kröger,Avichai Shimoni,Georgia Schilling,Rainer Schwerdtfeger,Martin Bornhäuser,Arnon Nagler,Axel R. Zander,Marion Heinzelmann,Ronald Brand,Gösta Gahrton,Curly Morris,Dietger Niederwieser,Theo de Witte +12 more
TL;DR: It is concluded that optimal donor selection is mandatory for a low non‐relapse mortality and high relapse incidence, which remains a major concern, should be improved by including post‐transplant strategies to upgrade remission status.
Journal ArticleDOI
Gene expression during chemically induced liver fibrosis: Effect of halofuginone on TGF-β signaling
Yulia Gnainsky,Z. Kushnirsky,G. Bilu,Y. Hagai,Olga Genina,Hanne Volpin,Rafael Bruck,Gadi Spira,Arnon Nagler,Norifumi Kawada,Katsutoshi Yoshizato,D. P. Reinhardt,T. A. Libermann,Mark Pines +13 more
TL;DR: The role of TGF-β signaling in liver fibrosis and especially its potential for pharmacological intervention is highlighted and halofuginone, which has demonstrated efficacy and tolerance in animals and humans, could become an effective and novel therapy for Liver fibrosis.
Journal ArticleDOI
Halofuginone, an inhibitor of collagen type I synthesis, prevents postoperative adhesion formation in the rat uterine horn model.
TL;DR: Halofuginone could be used as an important means of understanding the role of collagen inAdhesion formation and might become a novel and promising antifibrotic agent for preventing adhesion formation after pelvic surgery.
Journal ArticleDOI
Genetic variations in the heparanase gene (HPSE) associate with increased risk of GVHD following allogeneic stem cell transplantation: effect of discrepancy between recipients and donors.
TL;DR: A highly significant correlation of HPSE gene SNPs rs4693608 and rs4364254 and their combination with the risk of developing acute and extensive chronic GVHD is indicated and a possible mechanism for the aggressive behavior of T lymphocytes leading to GV HD is suggested.
Journal ArticleDOI
Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group.
Anne M. Spanjaart,Per Ljungman,Per Ljungman,Rafael de la Cámara,Gloria Tridello,Valentín Ortiz-Maldonado,Alvaro Urbano-Ispizua,Pere Barba,Mi Kwon,Dolores Caballero,Pierre Sesques,Emmanuel Bachy,Roberta Di Blasi,Catherine Thieblemont,Friso Calkoen,Pim G.N.J. Mutsaers,Johan Maertens,Livia Giannoni,Emma Nicholson,Matthew Collin,Carlos Pinho Vaz,Elisabetta Metafuni,Joaquin Martinez-Lopez,Fiona L Dignan,Josep-Maria Ribera,Arnon Nagler,František Folber,Robin Sanderson,Adrian Bloor,Fabio Ciceri,Nina Knelange,Francis Ayuk,Nicolaus Kröger,Marie José Kersten,Stephan Mielke,Stephan Mielke +35 more